What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice?

Brodie, Bruce R

What anti-thrombotic therapy is best with primary PCI for acute ST elevation myocardial infarction: how should the HORIZONS trial change current practice? [electronic resource] - Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions May 2008 - 816-21 p. digital

Publication Type: Journal Article

1522-726X

10.1002/ccd.21518 doi


Angioplasty, Balloon, Coronary--adverse effects
Anticoagulants--therapeutic use
Aspirin--therapeutic use
Cardiovascular Diseases--etiology
Clopidogrel
Fibrinolytic Agents--adverse effects
Hemorrhage--chemically induced
Heparin--therapeutic use
Hirudins
Humans
Myocardial Infarction--mortality
Patient Selection
Peptide Fragments--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Recombinant Proteins--therapeutic use
Research Design
Stents
Thrombin--antagonists & inhibitors
Thrombosis--etiology
Ticlopidine--analogs & derivatives
Treatment Outcome